 Home > Medical News > Latest Medical News > [Heavyweight] Chia Tai Tianqing will win the first copy of Lenvatinib

[Heavyweight] Chia Tai Tianqing will win the first copy of Lenvatinib

 Last Update: 2021-03-22
 Source: Internet
 Author: User

Tags

fda registration certificate

plant growth chamber

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, Chia Tai Tianqing Pharmaceutical Group entered the administrative examination and approval stage with generic 4 types of lenvatinib mesylate capsules.

Lenvatinib is an oral multi-target kinase inhibitor developed by Eisai, which can inhibit vascular endothelial growth factor receptor (VEGFR) 1-3, fibroblast growth factor receptor (FGFR) 1-4, platelet-derived Growth factor receptor (PDGFR) α, RET and KIT and other targets.

Lenvatinib mesylate capsule was approved for marketing in China in September 2018.

According to data from Meinenet, in 2019, the total sales of lentinib in Chinese urban public hospitals, county-level public hospitals, urban community centers, township health centers (referred to as Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 300 million yuan.

Registration application status of Lenvatinib mesylate capsules

Source: One-click search on Mi Nei.

At present, a total of 10 companies in the domestic market have submitted 4 types of listing applications for lenvatinib mesylate capsules, involving Chia Tai Tianqing, Simcere Pharmaceuticals, Qilu Pharmaceuticals, Kelun Pharmaceuticals, CSPC, Yangzijiang Pharmaceuticals and Osaikang Wait.

Source: Minet database

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.